Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia
2019 · Cancer Cell · 257 citations
https://doi.org/10.1016/j.ccell.2019.06.003
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
72
Papers
3.2K
Citations
20
h-index
23
i10-index
Bernhard Lehnertz is an academic researcher from Excell Research (United States). The author has contributed to research in topics: Acute Myeloid Leukemia Research & CRISPR and Genetic Engineering & Hematopoietic Stem Cell Transplantation. The author has an h-index of 20, co-authored 62 publications.
ORCID: 0000-0003-1523-1410https://doi.org/10.1016/j.ccell.2019.06.003
https://doi.org/10.1182/bloodadvances.2023010460
https://doi.org/10.3929/ethz-c-000792016
Click to start Chat